Creative Planning’s Tonix Pharmaceuticals TNXP Stock Holding History

Creative Planning’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$187K	Buy	+14,675	New	+$189K	﹤0.01%	3891
2021 Q2	–	Hold	0	–	-$21K	–	2555
2021 Q1	–	Hold	0	–	–	–	2431
2017 Q3	–	Hold	0	–	-$1K	–	3556
2017 Q2	–	Hold	0	–	–	–	4501
2017 Q1	–	Hold	0	–	–	–	4503
2016 Q4	–	Hold	0	–	–	–	4492
2016 Q3	–	Hold	0	–	–	–	4441
2016 Q2	–	Hold	0	–	–	–	3401
2016 Q1	–	Hold	0	–	–	–	3236
2015 Q4	–	Hold	0	–	–	–	2170

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning's TNXP Position: Q2 2026 in Review

Creative Planning opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 14,675 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #3891 among its holdings.

102 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Creative Planning held 14,675 shares of Tonix Pharmaceuticals worth $187K as of Q2 2026.
Tonix Pharmaceuticals was a new Creative Planning position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3891 holding.
102 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.